Expenditure on medical devices in Italy: report published by the Ministry of Health

01

Mar 2018

The analysis showed that the expenditure on medical devices (i.e., medical devices, active implantable medical devices, and in vitro diagnostic devices) in 2016 increased of 1.4% compared to 2015. The highest figure was registered for implantable medical devices (+3.7%).

The Regions with the highest volumes were Lombardia (EUR 599,008,730), Veneto (EUR 420,105,473), Emilia Romagna (EUR 394,547,901), and Toscana (EUR 378,124,997).

The top 4 classes of medical devices, accounting for 51.6% of the total expenditure in 2016, were the following:

  • Prosthetic implantable devices and osteosynthesis products: 20.8% of the total (+4.6% compared to 2015). Within this class, 85.6% were orthopaedic prostheses (49.4%) and vascular and cardiac prostheses (36.2%).
  • Devices for the cardiocirculatory apparatus: 12.1% of the total (+5.8% compared to 2015). Within this class, 80% were arterio-venous devices (54.2%), arrhythmology devices (13.2%), and guide-wires (12%).
  • Active implantable devices: 9.8% of the total (+5% compared to 2015). Within this class, 86.6% were devices for the cardiac functions.
  • Devices for administration and collection: 8.9% of the total (+9.4% compared to 2015). Within this class, 69% were conduits and tubes (30.4%), needles (22.6%), and liquid collection devices (15.9%).

See the report in Italian here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

24

Mar 2022

The HTA body of the Tuscany Regional Healthcare issues two types of documents: HTA forms and motivational forms. With a regional decree 2472 of February 10, 2022, Tuscany Regional Healthcare has published assessments of five medical devices of various therapeutic areas, such as cardiovascular and peripheral vascular areas.

Read more

07

Mar 2022

On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%.

Read more

04

Mar 2022

On February 14, 2022, the Danish Treatment Council (Behandlingsråd), a new body for assessing treatments and health technologies that became fully operational in late May 2021, has announced its symposium, which will take place in Aalborg on May 11, 2022.

Read more

14

Feb 2022

On January 28, 2022, the Institute for the Hospital Remuneration System (InEK) has published the list of the requests for innovation funding (NUB) that were submitted by the hospitals in 2021. The medical technologies belonging to the cardiovascular, ENT, eHealth, gastrointestinal, neuromodulation, neurovascular, orthopedic, and other technology groups obtained positive status 1.

Read more

07

Feb 2022

On January 20, 2022, the Federal Joint Committee (G-BA) has initiated an evaluation procedure for early benefit assessment for the use of a stent retriever (pRELAX by femtos) to treat vasospasm of cerebral arteries after subarachnoid hemorrhage.

Read more